Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: Efficacy and safety observations
Journal article published in 2018 by
S. Broesby-Olsen,
H. Vestergaard,
C. G. Mortz,
B. Jensen,
T. Havelund,
A. P. Hermann,
F. Siebenhaar,
M. B. Møller,
T. K. Kristensen,
C. Bindslev-Jensen 
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 